» Articles » PMID: 35845496

Molecular Mechanism of Betulin Palliative Therapy for Chronic Obstructive Pulmonary Disease (COPD) Based on Receptor Target of Gated Ion Channel

Overview
Journal Ann Transl Med
Date 2022 Jul 18
PMID 35845496
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to discover the molecular mechanism of betulin palliative therapy for chronic obstructive pulmonary disease (COPD) based on the receptor target of gated ion channel.

Methods: A COPD mouse model was developed. Changes in pulmonary ventilation function, pulmonary airway and vascular remodeling indicators, inflammatory cells, and inflammatory factors were determined after betulin intervention, and the pathological alterations of lung tissues were detected. An in vitro experimental model was constructed to observe the influence of betulin at varying concentrations on the proliferation of human bronchial epidermal cell line (16-HBE) cells and changes in inflammatory factors in cell supernatant. The expression levels of key proteins in 16-HBE cells transfected with overexpressed or silenced genes were determined through quantitative reverse transcription polymerase chain reaction (RT-qPCR) and Western blot.

Results: After betulin intervention, pulmonary ventilation function in the 20 mg/kg betulin and 40 mg/kg betulin groups was improved. Levels of white blood cells (WBCs), neutrophils (Ns), tumor necrosis factor (TNF), TNF-ɑ, interleukin (IL)-1β, and IL-6 in the 2 groups also decreased significantly (all P<0.05). The pathological changes in COPD mice were detected. After betulin intervention, the pathological injury of the lung was reduced, the pathological score decreased significantly, and the remodeling indicators of pulmonary airway and pulmonary vessels diminished remarkably (all P<0.05). Betulin had no effect on the proliferation of 16-HBE cells in vitro. After cigarette smoke extract (CSE) stimulation, the rate of survival for 16-HBE cells decreased significantly. After betulin treatment, the survival rate of 16-HBE cells augmented remarkably, and the levels of TNF-ɑ, IL-6, and IL-1β in cell supernatant reduced substantially (all P<0.05). 16-HBE with overexpression and knockdown of was constructed. After being treated with betulin, the relative expression levels of messenger RNA (mRNA) of ERK, JNK, rho-associated protein kinase (ROCK), nuclear factor-κB (NF-κB), and p38 in 16-HBE cells with overexpression or knockdown were decreased significantly (all P<0.05), but the above indicators were largely unchanged (all P>0.05).

Conclusions: Betulin relieved lung pathological injury, ameliorated lung ventilation function, and diminished the level of inflammatory factors in COPD mice, playing a therapeutic role via the signaling pathway.

Citing Articles

Differences in Airway Remodeling and Emphysematous Lesions between Rats Exposed to Smoke from New-Type and Conventional Tobacco Varieties.

Wei K, Li Y, Du B, Wu J Antioxidants (Basel). 2024; 13(5).

PMID: 38790616 PMC: 11117731. DOI: 10.3390/antiox13050511.


Therapeutic potential of natural products in inflammation: underlying molecular mechanisms, clinical outcomes, technological advances, and future perspectives.

Gouda N, Alshammari S, Abourehab M, Alshammari Q, Elkamhawy A Inflammopharmacology. 2023; 31(6):2857-2883.

PMID: 37950803 DOI: 10.1007/s10787-023-01366-y.


Betulin, an Anti-Inflammatory Triterpenoid Compound, Regulates MUC5AC Mucin Gene Expression through NF-kB Signaling in Human Airway Epithelial Cells.

Hossain R, Kim K, Jin F, Lee H, Lee C Biomol Ther (Seoul). 2022; 30(6):540-545.

PMID: 36203319 PMC: 9622319. DOI: 10.4062/biomolther.2022.093.

References
1.
Rabe K, Watz H . Chronic obstructive pulmonary disease. Lancet. 2017; 389(10082):1931-1940. DOI: 10.1016/S0140-6736(17)31222-9. View

2.
Yue Q, Deng X, Li Y, Zhang Y . Effects of Betulinic Acid Derivative on Lung Inflammation in a Mouse Model of Chronic Obstructive Pulmonary Disease Induced by Particulate Matter 2.5. Med Sci Monit. 2021; 27:e928954. PMC: 7885291. DOI: 10.12659/MSM.928954. View

3.
Sekar P, Huang D, Hsieh S, Chang S, Lin W . AMPK-dependent and independent actions of P2X7 in regulation of mitochondrial and lysosomal functions in microglia. Cell Commun Signal. 2018; 16(1):83. PMC: 6245559. DOI: 10.1186/s12964-018-0293-3. View

4.
Cao S, Yuan S, Hou Q . [Advance in the research on P2X7 and inflammatory respiratory diseases]. Yao Xue Xue Bao. 2013; 48(8):1183-8. View

5.
Jiang L, Caseley E, Muench S, Roger S . Structural basis for the functional properties of the P2X7 receptor for extracellular ATP. Purinergic Signal. 2021; 17(3):331-344. PMC: 8410900. DOI: 10.1007/s11302-021-09790-x. View